Loading... Please wait...
Sort by:
  • Biosimilars: Go-to-Market Case Studies
    Learn More Biosimilars: Go-to-Market Case Studies
    As the biosimilar sector matures, what are the key issues that are shaping commercial strategies? As physician and payer confidence in the use of biosimilars grows, US and European companies are having to rethink their...
  • Partnering in Digital Health: Pharma and Tech Companies
    Learn More Partnering in Digital Health: Pharma and Tech Companies
    The secret of successful digital health partnerships Digital health is guaranteed to play a huge part in the future of pharma. Innovative technology that can improve patient access, increase quality of care, boost...
  • Paying for Digital Health: Payer Insights (2019)
    Learn More Paying for Digital Health: Payer Insights (2019)
    Which digital health technologies are exciting payers? How and where can digital health technology improve patient outcomes and save payers money? Across the digital health field there are hundreds of applications...
  • The Role of Patient Journey Mapping in Patient Engagement
    Learn More The Role of Patient Journey Mapping in Patient Engagement
    Are you employing the latest technology and techniques to power your patient journey mapping? "Pharma companies first need to understand that their task is not to produce new product; their task is to provide a really...
  • Biomarkers and Companion diagnostics: Payer Insights
    Learn More Biomarkers and Companion diagnostics: Payer Insights
    What do you need to do to get payer support for companion diagnostics and biomarkers? The investment decisions made by the biggest players in core disease areas drive market trends—so it's crucial to understand...
  • Health Insurance Disruptors: Going Digital
    Learn More Health Insurance Disruptors: Going Digital
    Health insurance: how to thrive in an increasingly digital health world Health insurers are being challenged to develop a portfolio of digital services with limited knowledge of their effectiveness and at a considerable...
  • Pricing Transparency in Pharma
    Learn More Pricing Transparency in Pharma
    Pharma challenged to engage and shape the drug pricing transparency debate Anxieties about rising drug prices is fuelling an ever louder global demand for price transparency—and reformers are getting their message...
  • Regulating Digital Health
    Learn More Regulating Digital Health
    As digital health progressively enters mainstream therapy, how should it be regulated and to what outcome? Digital health is booming and as investment in digital health technology grows more products and services will...
  • The Future of Disease Interception
    Learn More The Future of Disease Interception
    What does pharma need to do to develop this radical health model of the future? Disease interception is a novel healthcare model that identifies, treats and sometimes cures disease before it is fully manifested. There...
  • The Future of Virtual Healthcare
    Learn More The Future of Virtual Healthcare
    What strategy should pharma be pursuing in virtual healthcare? Applications for virtual healthcare engagement are quickly evolving beyond websites and apps towards advanced tools such as virtual assistants and virtual...
  • The Impact of 5G on Healthcare
    Learn More The Impact of 5G on Healthcare
    Health insurance: how to thrive in an increasingly digital health world 5G wireless network technology has the potential to revolutionise pharma's business. Combined with advances in artificial intelligence and machine...
  • The Future of Key Account Management in Pharma
    Learn More The Future of Key Account Management in Pharma
    Are you ready for fundamental disruption to key account management practice? While the Key Account Management (KAM) role will continue to prioritise the development of long-term, sustainable partnerships between...
  • Trends in Investment by Big Pharma
    Learn More Trends in Investment by Big Pharma
    What direction are big pharma investments taking? The investment decisions made by the biggest players in core disease areas drive market trends—so it's crucial to understand where the big money is going and why...
  • Benchmarking Key Account Management Capabilities (2019)
    Learn More Benchmarking Key Account Management Capabilities (2019)
    What factors determine a Key Account Manager (KAM) team's size and structure? At what stage in a product's lifecycle are KAMs assigned and how many brands should a typical KAM support? What personal attributes and...
  • Biosimilars: The Importance of Real-World Evidence (2019)
    Learn More Biosimilars: The Importance of Real-World Evidence (2019)
    Are you generating the right RWE to influence the right stakeholders? As the biosimilar sector continues to evolve and experience of their use deepens, what role should real-world evidence (RWE) now take in stakeholder...
  • Real-World Data Capabilities: Benchmarking Pharma Companies (2019)
    Learn More Real-World Data Capabilities: Benchmarking Pharma Companies (2019)
    Are you fully and efficiently exploiting real-world data across your business? The impact of real-world data (RWD) is growing but few companies are fully exploiting its potential across all clinical and commercial areas...

customer.service@firstwordpharma.com

All Contents Copyright © 2019 Doctor's Guide Publishing Limited All Rights Reserved